| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catheterization, Central Venous | 11 | 2015 | 84 | 1.140 |
Why?
|
| Cross Infection | 15 | 2019 | 170 | 1.130 |
Why?
|
| Intubation, Intratracheal | 4 | 2019 | 198 | 0.900 |
Why?
|
| Critical Illness | 6 | 2020 | 342 | 0.850 |
Why?
|
| Catheter-Related Infections | 6 | 2015 | 42 | 0.730 |
Why?
|
| Catheters, Indwelling | 6 | 2010 | 67 | 0.700 |
Why?
|
| Bacteremia | 5 | 2019 | 92 | 0.690 |
Why?
|
| Critical Care | 6 | 2015 | 416 | 0.650 |
Why?
|
| Oxygen | 6 | 2008 | 323 | 0.620 |
Why?
|
| Muscle, Skeletal | 5 | 2008 | 791 | 0.530 |
Why?
|
| Carbon Dioxide | 4 | 2015 | 81 | 0.520 |
Why?
|
| Anesthesiology | 5 | 2015 | 40 | 0.510 |
Why?
|
| Equipment Contamination | 8 | 2015 | 34 | 0.490 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2007 | 465 | 0.470 |
Why?
|
| Asbestos | 1 | 2015 | 11 | 0.460 |
Why?
|
| Connective Tissue Diseases | 1 | 2015 | 11 | 0.460 |
Why?
|
| Glass | 1 | 2015 | 23 | 0.460 |
Why?
|
| Airway Management | 3 | 2020 | 60 | 0.450 |
Why?
|
| Sepsis | 3 | 2012 | 309 | 0.430 |
Why?
|
| Infection Control | 8 | 2015 | 106 | 0.430 |
Why?
|
| Administrative Personnel | 1 | 2014 | 30 | 0.410 |
Why?
|
| Tissue and Organ Procurement | 1 | 2014 | 40 | 0.410 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2015 | 147 | 0.410 |
Why?
|
| Lactic Acid | 2 | 2010 | 75 | 0.370 |
Why?
|
| Occupational Exposure | 1 | 2015 | 322 | 0.370 |
Why?
|
| Candidemia | 3 | 2017 | 9 | 0.350 |
Why?
|
| Surgical Wound Infection | 3 | 2017 | 126 | 0.330 |
Why?
|
| Lung | 1 | 2015 | 970 | 0.320 |
Why?
|
| Referral and Consultation | 1 | 2014 | 449 | 0.320 |
Why?
|
| Strongyloidiasis | 1 | 2010 | 10 | 0.310 |
Why?
|
| Gram-Positive Bacteria | 1 | 2010 | 35 | 0.310 |
Why?
|
| Lung Injury | 1 | 2010 | 36 | 0.310 |
Why?
|
| Pancreatitis | 1 | 2010 | 96 | 0.300 |
Why?
|
| Immunocompromised Host | 1 | 2010 | 104 | 0.290 |
Why?
|
| Intensive Care Units | 8 | 2017 | 437 | 0.280 |
Why?
|
| Staphylococcal Infections | 4 | 2017 | 131 | 0.280 |
Why?
|
| Humans | 47 | 2020 | 65883 | 0.270 |
Why?
|
| Catheterization, Peripheral | 6 | 2011 | 51 | 0.270 |
Why?
|
| Hand Hygiene | 3 | 2016 | 10 | 0.260 |
Why?
|
| Hand Strength | 1 | 2007 | 34 | 0.250 |
Why?
|
| Hand Disinfection | 6 | 2015 | 18 | 0.250 |
Why?
|
| Veins | 1 | 2007 | 63 | 0.250 |
Why?
|
| Anesthesia | 3 | 2015 | 52 | 0.240 |
Why?
|
| Antibiotic Prophylaxis | 5 | 2010 | 59 | 0.240 |
Why?
|
| Hypoxia | 2 | 2015 | 121 | 0.240 |
Why?
|
| Gram-Negative Bacterial Infections | 2 | 2017 | 26 | 0.230 |
Why?
|
| Gram-Positive Bacterial Infections | 2 | 2017 | 31 | 0.230 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2006 | 90 | 0.230 |
Why?
|
| Wounds and Injuries | 2 | 2007 | 253 | 0.230 |
Why?
|
| Anti-Bacterial Agents | 6 | 2015 | 809 | 0.230 |
Why?
|
| Male | 28 | 2019 | 31446 | 0.220 |
Why?
|
| Candida | 2 | 2015 | 37 | 0.220 |
Why?
|
| Jehovah's Witnesses | 1 | 2004 | 19 | 0.210 |
Why?
|
| Religion and Medicine | 1 | 2004 | 20 | 0.210 |
Why?
|
| Blood Loss, Surgical | 1 | 2004 | 65 | 0.210 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2015 | 279 | 0.200 |
Why?
|
| Tobramycin | 1 | 2003 | 6 | 0.200 |
Why?
|
| Shock, Hemorrhagic | 1 | 2003 | 19 | 0.200 |
Why?
|
| Klebsiella Infections | 1 | 2003 | 25 | 0.200 |
Why?
|
| Monitoring, Intraoperative | 1 | 2003 | 47 | 0.200 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2003 | 59 | 0.200 |
Why?
|
| Operating Rooms | 5 | 2016 | 60 | 0.200 |
Why?
|
| Splanchnic Circulation | 1 | 2003 | 16 | 0.190 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2003 | 44 | 0.190 |
Why?
|
| Anemia | 1 | 2004 | 132 | 0.190 |
Why?
|
| Stomach | 1 | 2003 | 87 | 0.190 |
Why?
|
| Pneumonia, Bacterial | 1 | 2003 | 91 | 0.190 |
Why?
|
| Hand | 4 | 2016 | 79 | 0.190 |
Why?
|
| Middle Aged | 17 | 2019 | 18526 | 0.180 |
Why?
|
| Monitoring, Physiologic | 1 | 2003 | 170 | 0.180 |
Why?
|
| Prospective Studies | 11 | 2016 | 3341 | 0.180 |
Why?
|
| Adult | 20 | 2017 | 17601 | 0.180 |
Why?
|
| Exercise | 1 | 2007 | 970 | 0.150 |
Why?
|
| Fungemia | 1 | 2019 | 6 | 0.150 |
Why?
|
| Nitroprusside | 1 | 2019 | 14 | 0.150 |
Why?
|
| Female | 21 | 2019 | 34470 | 0.140 |
Why?
|
| Liver | 1 | 2003 | 879 | 0.140 |
Why?
|
| Aged | 14 | 2019 | 15161 | 0.140 |
Why?
|
| Hypovolemia | 2 | 2008 | 17 | 0.130 |
Why?
|
| Rifampin | 2 | 2010 | 26 | 0.130 |
Why?
|
| Minocycline | 2 | 2010 | 28 | 0.130 |
Why?
|
| Chlorhexidine | 3 | 2015 | 17 | 0.130 |
Why?
|
| Postoperative Period | 4 | 2015 | 130 | 0.130 |
Why?
|
| Posture | 1 | 2017 | 128 | 0.130 |
Why?
|
| Schizophrenia | 1 | 2019 | 279 | 0.120 |
Why?
|
| Frail Elderly | 1 | 2017 | 115 | 0.120 |
Why?
|
| Antipsychotic Agents | 1 | 2019 | 308 | 0.120 |
Why?
|
| Pseudomonas Infections | 1 | 2017 | 73 | 0.120 |
Why?
|
| Intraoperative Care | 1 | 2016 | 38 | 0.120 |
Why?
|
| Emergency Medical Services | 1 | 2019 | 266 | 0.120 |
Why?
|
| Anti-Infective Agents | 2 | 2010 | 154 | 0.120 |
Why?
|
| Brain Death | 1 | 2015 | 15 | 0.120 |
Why?
|
| Blood Gas Analysis | 1 | 2015 | 36 | 0.120 |
Why?
|
| Apnea | 1 | 2015 | 33 | 0.110 |
Why?
|
| Antibodies, Antinuclear | 1 | 2015 | 42 | 0.110 |
Why?
|
| Waiting Lists | 1 | 2015 | 55 | 0.110 |
Why?
|
| Lung Transplantation | 1 | 2015 | 75 | 0.110 |
Why?
|
| Antisepsis | 3 | 2011 | 7 | 0.110 |
Why?
|
| Enterococcus faecalis | 1 | 2015 | 11 | 0.110 |
Why?
|
| Respiratory Function Tests | 1 | 2015 | 195 | 0.110 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2015 | 61 | 0.110 |
Why?
|
| Central Venous Catheters | 1 | 2015 | 17 | 0.110 |
Why?
|
| Self Report | 1 | 2017 | 395 | 0.110 |
Why?
|
| Oxygen Consumption | 2 | 2007 | 213 | 0.110 |
Why?
|
| Shock, Septic | 2 | 2005 | 89 | 0.100 |
Why?
|
| Brain Injuries | 1 | 2015 | 141 | 0.100 |
Why?
|
| Catheterization | 3 | 2002 | 112 | 0.100 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 382 | 0.100 |
Why?
|
| Consensus | 2 | 2012 | 174 | 0.100 |
Why?
|
| Time Factors | 5 | 2015 | 3780 | 0.090 |
Why?
|
| Anti-Infective Agents, Local | 2 | 2010 | 29 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 1572 | 0.090 |
Why?
|
| Environment, Controlled | 1 | 2012 | 3 | 0.090 |
Why?
|
| Disease Reservoirs | 1 | 2012 | 10 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2015 | 338 | 0.090 |
Why?
|
| Equipment Design | 2 | 2015 | 374 | 0.090 |
Why?
|
| Massachusetts | 3 | 2017 | 2161 | 0.090 |
Why?
|
| Terminology as Topic | 1 | 2012 | 145 | 0.080 |
Why?
|
| Silver Sulfadiazine | 1 | 2010 | 3 | 0.080 |
Why?
|
| Antimetabolites | 1 | 2010 | 18 | 0.080 |
Why?
|
| Fluorouracil | 1 | 2010 | 68 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 2012 | 151 | 0.080 |
Why?
|
| Sensitivity and Specificity | 3 | 2015 | 1172 | 0.080 |
Why?
|
| Strongyloides stercoralis | 1 | 2010 | 12 | 0.080 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 3 | 2015 | 11 | 0.080 |
Why?
|
| Evidence-Based Medicine | 4 | 2011 | 464 | 0.080 |
Why?
|
| Postoperative Complications | 1 | 2017 | 1336 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 770 | 0.080 |
Why?
|
| United States | 6 | 2017 | 8192 | 0.080 |
Why?
|
| Puerto Rico | 1 | 2010 | 143 | 0.080 |
Why?
|
| Bacterial Adhesion | 1 | 2010 | 65 | 0.080 |
Why?
|
| Feces | 1 | 2010 | 123 | 0.080 |
Why?
|
| Diagnosis, Differential | 2 | 2010 | 993 | 0.080 |
Why?
|
| Logistic Models | 2 | 2017 | 1274 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 1663 | 0.070 |
Why?
|
| Hemodynamics | 2 | 2007 | 253 | 0.070 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2010 | 183 | 0.070 |
Why?
|
| Risk Factors | 4 | 2017 | 5478 | 0.070 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2007 | 25 | 0.070 |
Why?
|
| Hematinics | 1 | 2007 | 9 | 0.070 |
Why?
|
| Partial Pressure | 1 | 2007 | 9 | 0.060 |
Why?
|
| Erythropoietin | 1 | 2007 | 38 | 0.060 |
Why?
|
| Immobilization | 1 | 2007 | 14 | 0.060 |
Why?
|
| Neuromuscular Agents | 1 | 2007 | 16 | 0.060 |
Why?
|
| Erythrocyte Transfusion | 1 | 2007 | 77 | 0.060 |
Why?
|
| Leukocyte Reduction Procedures | 1 | 2006 | 3 | 0.060 |
Why?
|
| Hypothermia | 1 | 2006 | 15 | 0.060 |
Why?
|
| Hypnotics and Sedatives | 1 | 2007 | 66 | 0.060 |
Why?
|
| Resuscitation | 2 | 2005 | 67 | 0.060 |
Why?
|
| Transfusion Reaction | 1 | 2006 | 46 | 0.060 |
Why?
|
| Rats, Wistar | 2 | 2003 | 184 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2003 | 2328 | 0.060 |
Why?
|
| Temperature | 1 | 2007 | 317 | 0.060 |
Why?
|
| Perioperative Care | 1 | 2006 | 89 | 0.060 |
Why?
|
| Protein C | 1 | 2005 | 26 | 0.060 |
Why?
|
| Cervical Vertebrae | 1 | 2007 | 123 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 5685 | 0.060 |
Why?
|
| Obesity, Morbid | 1 | 2007 | 98 | 0.060 |
Why?
|
| Emergencies | 1 | 2005 | 124 | 0.060 |
Why?
|
| Blood Pressure | 2 | 2007 | 537 | 0.050 |
Why?
|
| Drug Resistance, Microbial | 1 | 2004 | 47 | 0.050 |
Why?
|
| Adolescent | 4 | 2011 | 6372 | 0.050 |
Why?
|
| Animals | 4 | 2010 | 21498 | 0.050 |
Why?
|
| Cardiotonic Agents | 1 | 2004 | 54 | 0.050 |
Why?
|
| Fluid Therapy | 1 | 2004 | 46 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2015 | 208 | 0.050 |
Why?
|
| Health Personnel | 3 | 2015 | 393 | 0.050 |
Why?
|
| Vasoconstrictor Agents | 1 | 2004 | 71 | 0.050 |
Why?
|
| Skin | 3 | 2015 | 436 | 0.050 |
Why?
|
| Respiration, Artificial | 2 | 2007 | 301 | 0.050 |
Why?
|
| Microelectrodes | 1 | 2003 | 14 | 0.050 |
Why?
|
| Intubation | 1 | 2003 | 10 | 0.050 |
Why?
|
| Hepatic Veins | 1 | 2003 | 13 | 0.050 |
Why?
|
| Aspartate Aminotransferases | 1 | 2003 | 35 | 0.050 |
Why?
|
| Ventilators, Mechanical | 1 | 2003 | 28 | 0.050 |
Why?
|
| Accidents, Traffic | 1 | 2004 | 140 | 0.050 |
Why?
|
| Klebsiella pneumoniae | 1 | 2003 | 29 | 0.050 |
Why?
|
| Blood Transfusion | 1 | 2004 | 167 | 0.050 |
Why?
|
| Manometry | 1 | 2003 | 28 | 0.050 |
Why?
|
| Gastric Mucosa | 1 | 2003 | 53 | 0.050 |
Why?
|
| Comorbidity | 1 | 2006 | 1122 | 0.050 |
Why?
|
| Rats | 2 | 2003 | 2005 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2019 | 749 | 0.050 |
Why?
|
| Length of Stay | 3 | 2017 | 829 | 0.050 |
Why?
|
| Subclavian Artery | 1 | 2002 | 26 | 0.050 |
Why?
|
| Swine | 1 | 2003 | 398 | 0.050 |
Why?
|
| Incidence | 1 | 2006 | 1434 | 0.050 |
Why?
|
| Coronary Disease | 1 | 2003 | 247 | 0.050 |
Why?
|
| Ventilator Weaning | 1 | 2002 | 21 | 0.050 |
Why?
|
| Liquid Ventilation | 1 | 2002 | 4 | 0.040 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2002 | 27 | 0.040 |
Why?
|
| Biomarkers | 2 | 2008 | 1506 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2015 | 757 | 0.040 |
Why?
|
| APACHE | 2 | 2017 | 42 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2003 | 292 | 0.040 |
Why?
|
| Bacteria | 1 | 2004 | 337 | 0.040 |
Why?
|
| Societies, Medical | 2 | 2015 | 401 | 0.040 |
Why?
|
| Phenotype | 2 | 2015 | 1236 | 0.040 |
Why?
|
| Fluorocarbons | 1 | 2002 | 56 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 1117 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 1720 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2017 | 6961 | 0.040 |
Why?
|
| Algorithms | 2 | 2004 | 1060 | 0.040 |
Why?
|
| Clozapine | 1 | 2019 | 32 | 0.040 |
Why?
|
| Risk | 2 | 2015 | 375 | 0.040 |
Why?
|
| Laryngoscopy | 1 | 2019 | 61 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2019 | 193 | 0.040 |
Why?
|
| Prognosis | 1 | 2003 | 1793 | 0.030 |
Why?
|
| Child | 5 | 2011 | 4656 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 462 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2017 | 2116 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2002 | 535 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2001 | 333 | 0.030 |
Why?
|
| Blood Culture | 1 | 2017 | 8 | 0.030 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 69 | 0.030 |
Why?
|
| Soft Tissue Infections | 1 | 2017 | 48 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2017 | 216 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 2017 | 90 | 0.030 |
Why?
|
| Linear Models | 1 | 2017 | 405 | 0.030 |
Why?
|
| Urinary Tract Infections | 1 | 2017 | 97 | 0.030 |
Why?
|
| Mortality | 1 | 2017 | 162 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2019 | 1030 | 0.030 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2015 | 34 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2015 | 122 | 0.030 |
Why?
|
| Moraxella | 1 | 2015 | 1 | 0.030 |
Why?
|
| Acinetobacter | 1 | 2015 | 2 | 0.030 |
Why?
|
| Enterobacter | 1 | 2015 | 5 | 0.030 |
Why?
|
| Pseudomonas | 1 | 2015 | 8 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2011 | 2090 | 0.030 |
Why?
|
| Staphylococcus | 1 | 2015 | 17 | 0.030 |
Why?
|
| Geography | 1 | 2015 | 37 | 0.030 |
Why?
|
| Candida glabrata | 1 | 2015 | 1 | 0.030 |
Why?
|
| Candida tropicalis | 1 | 2015 | 2 | 0.030 |
Why?
|
| Respiration | 1 | 2015 | 97 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 309 | 0.030 |
Why?
|
| Gram-Negative Bacteria | 1 | 2015 | 57 | 0.030 |
Why?
|
| Limit of Detection | 1 | 2015 | 49 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2019 | 5836 | 0.030 |
Why?
|
| Candida albicans | 1 | 2015 | 61 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 106 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2015 | 97 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2015 | 267 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2007 | 710 | 0.030 |
Why?
|
| ROC Curve | 1 | 2015 | 295 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 2015 | 125 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 498 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2015 | 183 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 932 | 0.020 |
Why?
|
| Gloves, Surgical | 1 | 2012 | 3 | 0.020 |
Why?
|
| Axilla | 1 | 2012 | 19 | 0.020 |
Why?
|
| Nasopharynx | 1 | 2012 | 21 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2012 | 34 | 0.020 |
Why?
|
| Bacteriological Techniques | 1 | 2012 | 29 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 149 | 0.020 |
Why?
|
| Europe | 1 | 2012 | 200 | 0.020 |
Why?
|
| Alcohols | 1 | 2011 | 13 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2010 | 59 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2010 | 142 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 638 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2011 | 310 | 0.020 |
Why?
|
| Forearm | 1 | 2008 | 23 | 0.020 |
Why?
|
| Lower Body Negative Pressure | 1 | 2007 | 8 | 0.020 |
Why?
|
| Epoetin Alfa | 1 | 2007 | 2 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2007 | 47 | 0.020 |
Why?
|
| Trauma Severity Indices | 1 | 2007 | 33 | 0.020 |
Why?
|
| Blood Volume | 1 | 2007 | 40 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2007 | 84 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2015 | 2791 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2007 | 136 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2011 | 1441 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2007 | 420 | 0.010 |
Why?
|
| Infant | 1 | 2011 | 1721 | 0.010 |
Why?
|
| Heart Rate | 1 | 2007 | 335 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2007 | 346 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2007 | 746 | 0.010 |
Why?
|
| Thrombosis | 1 | 2007 | 207 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2007 | 302 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2007 | 556 | 0.010 |
Why?
|
| Environmental Monitoring | 1 | 2004 | 155 | 0.010 |
Why?
|
| Blood Pressure Monitors | 1 | 2002 | 4 | 0.010 |
Why?
|
| Umbilical Arteries | 1 | 2002 | 10 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 2002 | 16 | 0.010 |
Why?
|
| Jugular Veins | 1 | 2002 | 28 | 0.010 |
Why?
|
| Cost Control | 1 | 2002 | 24 | 0.010 |
Why?
|
| Hydrocarbons, Brominated | 1 | 2002 | 3 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 2002 | 23 | 0.010 |
Why?
|
| Diagnosis-Related Groups | 1 | 2002 | 86 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2002 | 213 | 0.010 |
Why?
|
| Random Allocation | 1 | 2002 | 200 | 0.010 |
Why?
|
| Home Care Services | 1 | 2002 | 105 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2002 | 375 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 4887 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2002 | 579 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2004 | 740 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2002 | 318 | 0.010 |
Why?
|
| Hospitals | 1 | 2002 | 399 | 0.010 |
Why?
|
| Age Factors | 1 | 2002 | 1595 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2002 | 529 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2002 | 881 | 0.010 |
Why?
|
| Hospitalization | 1 | 2002 | 1404 | 0.010 |
Why?
|